Black Rock Inc. Aurinia Pharmaceuticals Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Black Rock Inc. holds 9,272,162 shares of AUPH stock, worth $142 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,272,162
Previous 8,662,978
7.03%
Holding current value
$142 Million
Previous $43.4 Million
21.99%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding AUPH
# of Institutions
269Shares Held
69.3MCall Options Held
984KPut Options Held
574K-
Tang Capital Management LLC San Diego, CA11.3MShares$174 Million5.69% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$60.9 Million2.74% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA3.37MShares$51.8 Million0.03% of portfolio
-
State Street Corp Boston, MA2.69MShares$41.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.95MShares$29.9 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $2.18B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...